Omega Therapeutics, Inc. (OMGA) Financials
OMGA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 183.7 million | 142.3 million |
2023-12-31 | 204.4 million | 146.4 million |
2023-09-30 | 217.8 million | 141.8 million |
2023-06-30 | 229.0 million | 133.1 million |
OMGA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -12.3 million | 3.4 million |
2023-12-31 | -18.2 million | 2.1 million |
2023-09-30 | -23.8 million | 2.3 million |
2023-06-30 | -24.3 million | 2.2 million |
OMGA Net Income
No data available :(
OMGA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 60.0 million | - | 109.7 million |
2023-12-31 | 73.4 million | - | 109.5 million |
2023-09-30 | 89.3 million | - | 111.3 million |
2023-06-30 | 113.0 million | 11.6 million | 98.7 million |
OMGA Shares Outstanding
OMGA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 535000 | 15.4 million | 7.4 million | - |
2023-12-31 | 1.1 million | 15.5 million | 6.2 million | -1.8 million |
2023-09-30 | 724000 | 16.5 million | 7.9 million | - |
2023-06-30 | 1.0 million | 25.0 million | 6.2 million | - |
OMGA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 2.4 million | - |
2023-12-31 | 989000 | 1.8 million |
2023-09-30 | 831000 | 1.9 million |
2023-06-30 | 759000 | 1.8 million |
OMGA
Price: $2.41
52 week price:
Earnings Per Share: -1.80 USD
P/E Ratio: -1.64
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 118.3 million